kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the ZBIO dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for ZBIO.

ZBIO

Zenas BioPharma, Inc.
Healthcare · Biotechnology
$148.23 sample
+1.56 (+1.06%) 1D
☆ Watch
Market cap
$476.8B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-06
Alerts
8
Price$148.23 +5.48% 3M daily closessample
148.95136.47
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 21INSInsider sell: Director
  • Oct 16INSInsider buy: EVP, Operations
  • Oct 09INSInsider sell: Director
  • Oct 06SECForm 144 filed
  • Sep 29INSInsider sell: General Counsel
  • Sep 22INSInsider buy: Chief Executive Officer
  • Sep 16SECDEF 14A filed
  • Sep 09SEC8-K filed: material event
Sign up to see the real ZBIO record →

Company facts

SEC EDGAR registration
Name
Zenas BioPharma, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+36sample, -100 to +100
Reporting currency
USD

Who is positioning in ZBIO

sample
Insiders
34 insider transactions over 90 days, net selling, $635.9M
Congress
1 members traded over 90 days
Institutions · 13F
22 funds hold $7.3B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$20.4B +13.3% y/y
Q4 2024Q3 2026
Inventory$13.0B +22.2% y/y
Q4 2024Q3 2026
Accounts receivable$9.6B +21.4% y/y
Q4 2024Q3 2026
Total debt$25.9B +11.7% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$421.9B +8.6% 3M
Sample peer B
$348.7B -1.8% 3M
Sample peer C
$429.0B +9.7% 3M
Sample peer D
$330.1B +16.5% 3M
Sample peer E
$397.5B +6.2% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not ZBIO's real figure. Nothing here is investment advice.